The development of a new drug is an extremely expensive and risky venture. The average
cost per a successful new chemical entity is estimated to exceed USD 200 million, and after …

Positron emission tomography (or PET) is a non-destructive imaging technique in nuclear
medicine with several unique properties: high sensitivity, low radiation dose, possibility to …

Can drug development and evaluation be improved by the use of positron emission
tomography (PET)? PET is now well established and many PET centres participate in …

Publisher Summary This chapter describes the design and synthesis of radiotracers labeled
with the short lived cyclotron produced nuclides and the application of positron emission …

Full text: The positron emission tomography (PET) is an unique, non-invasive, powerful
diagnostic tool at the forefront of modern functional imaging in clinical nuclear medicine …

A Centre for Positron Emission Tomography (PET) has been operational within the
Department of Nuclear Medicine at the Austin & Repatriation Medical Centre (A&RMC) in …

Positron Emission Tomography (PET) is a sophisticated nuclear imaging modality that
affords researchers the ability to conduct both functional and molecular imaging on …

This paper provides a brief review of the radiochemistry of radiopharmaceuticals used in
positron emission tomography (PET). It includes some history of PET, the basic formation of …

Abstract Positron Emission Tomography is at the present time in a growth phase with an
increasing number of clinical facilities showing interest in the use of PET in routine practice …

There are three major technical components of positron emission tomography (PET): PET
scanner, cyclotron production of radiopharmaceuticals, and biological assays of normal and …